Nov 28

Would John Lannan Be A Better Risk Than Bringing Back Pelfrey?

On Tuesday, Nationals beat writer William Ladson, tweeted that he expects the Nats to non-tender lefthanded starting pitcher John Lannan on Friday. Ladson also added that he believed Lannan would be a solid fit for the Mets.

I took a quick glance at Lannan’s career numbers and the first thing that came to mind was, “I’ve seen these numbers before”. I was looking at a lefthanded version of Mike Pelfrey.

Lannan, a New York native, has posted career marks of a 4.01 ERA and a 1.424 WHIP in 134 major league starts, while Pelfrey counters with a 4.36 ERA and 1.458 in 149 starts. Pelfrey had the benefit of pitching in a much friendlier pitcher’s park. Lannan also has a career 7.0 WAR compared to 5.4 for Pelfrey, despite a half season less playing time.

There has been talk of non-tendering Pelfrey on Friday, but bringing him back on a one year deal for much less money than he the $5.6 million he earned in 2012. As you know, he’s trying to comeback from Tommy John surgery which he had performed last May.

Given Lannan is a lefthander, is healthy, and has posted slightly better numbers in his career than Pelfrey, maybe Ladson is right, maybe we should take a closer look at Lannan and consider if he would be a better fit at this time than Mike Pelfrey would.

There’s no room for Lannan in Washington’s rotation. When they traded for Gio Gonzalez and signed Edwin Jackson his fate had been sealed. But the 28-year old has shown flashes of brilliance before and usually southpaws take a little longer to mature than righthanders do. He took his demotion to Triple-A pretty last season pretty hard and has a chip on his shoulder. The timing could be right for this low risk, high reward player.

He could be a solid addition for the Mets and someone we could use to give the team some depth in case of injury to one of our starters down the road.

Nov 24

Making Cases For Pelfrey And Torres To Return

After writing about Jon Niese and untouchable Mets yesterday, I thought I’d take a different approach and consider those Mets believed to be out the door.

Say hello to Mike Pelfrey and Andres Torres. Both long thought to be gone, but upon further review cases can be made for their return.

PELFREY: Making a case for his return. (Daily News)

The 28-year-old Pelfrey made $5.68 million in an injury shortened 2012 and is expected to hit the market with a career 50-54 record. He is arbitration eligible with Scott Boras as his agent, all which should make the Mets deathly afraid.

Quite bluntly: Even at 20 percent off his 2012 salary, the Mets think that is too high, which is why they won’t tender him and say good-bye after a disappointedly short-lived career in Flushing. He had a couple of solid seasons, even All-Star worthy in 2010, but regressed in 2011 and was hurt last year.

He never reached the level expected of a first-round pick while others, such as Tim Lincecum and Matt Cain sprinted past him into elite status. Unquestionably, Pelfrey has the physical tools to excel, but dramatically underachieved. A combination of a lack of poise – who can forget the three-balk game? – poor pitch selection, mechanics, and although he’ll deny it – spotty confidence – lead to mediocrity.

Continue reading

Oct 26

2012 Mets Player Review: Jenrry Mejia And Other Spot Starters

 

JENRRY MEJIA, RHP

PRESEASON EXPECTATIONS: The Mets knew they had pitching issues entering spring training, so by definition they expected a need for emergency starters. They opened the season with Mike Pelfrey, Johan Santana, R.A. Dickey, Jon Niese and Dillon Gee as their rotation. Santana and Niese were coming off injuries, and nobody knew what to expect from Pelfrey and Gee. Veteran Chris Young was signed for the inevitable insurance and closed the season in the rotation. The Mets forecasted starts for Matt Harvey and Jenrry Mejia, but most likely as September call-ups. The Mets figured they had Miguel Batista, Jenrry Mejia and Jeurys Familia to make emergency starts in the event of injuries.

WHAT THEY GOT: Injuries claimed Pelfrey, Santana and Gee, and before it was over eight other pitchers started 58 games for the Mets. That’s roughly a third of their games. That, as much as any other statistic, explains this season. Young, who was signed in March, made 20 starts after recovering from shoulder surgery. He proved to be a reliable innings eater, so much, in fact, that it might earn him a contract elsewhere. Veterans who gobble up innings are always valuable. Harvey was so impressive in his shot that he’s going into next season in the rotation. For those not yet earmarked for a roster spot next season, Jeremy Hefner started 13 games, followed by Batista (5), Collin McHugh (4), Mejia (3), Chris Schwinden (2) and Familia (1). McHugh and Hefner had their moments, both good and bad, but made no lasting impression either way. The most puzzling is Mejia, who was coming off surgery. Although his numbers are better as a starter, the Mets still don’t have a long-term plan for him as there are factions in the organization who believe he’s better suited coming out of the bullpen. The Mets like Familia’s potential, but he was hit hard when he got the ball. McHugh, Hefner and Schwinden did nothing to separate themselves from the pack and Batista was what they expected, a long-man stop-gap.

 

LOOKING AT 2013: There is a need for Young, but he’s low on their priorities, even if the Mets don’t tender Pelfrey. Harvey is in the rotation, but ten starts isn’t a big window, so who wouldn’t be surprised if there’s a setback? McHugh, Hefner and Schwinden will probably open the season in the minor leagues and Batista could again be in the bullpen. Familia will be in the minors. The biggest question is Mejia’s role. The Mets have confused him by shuttling him between roles. For his own good and that of the team, the Mets should choose a role and stay that course until he proves incapable. Once a highly-touted prospect, Mejia seems to be regressing.

Oct 20

2012 Mets Player Review: Mike Pelfrey

MIKE PELFREY, RHP

PRESEASON EXPECTATIONS: After falling far short of the expectations of a No. 1 draft choice in 2005 – the ninth overall selection – Mike Pelfrey had what was thought to be a breakout year in 2010 when he went 15-9 with a 3.66 ERA and career high 204 innings. Pelfrey did not have dominating numbers, but clearly made progressions in his approach to pitching that suggested he might become the pitcher the Mets hoped. Pelfrey finally was pitching with poise and guile. There was an undeniable composure he never displayed before and his pitch selection was far better. Hitters could no longer sit on his fastball because he was getting his secondary pitches over in fastball counts. Could Pelfrey finally become an ace? Well, no. Pelfrey regressed in 2011 going 7-13 with a 4.74 ERA. Hitters ripped him at a .286 clip with a .344 on-base percentage and crushed 21 homers. With two back-to-back polar opposite seasons, the Mets didn’t know what to expect from him for the $5.6 million they would pay.

2012 SEASON REVIEW: Pelfrey started fast this year with a 2.29 ERA in three starts and resembled his 2010 performance. He pitched with composure in that window and the thought was perhaps he would take the next step. However, Pelfrey sustained an elbow injury and underwent Tommy John surgery that finished his season. Would it also finish his Mets’ career?

LOOKING AT 2013: The cost conscious Mets, despite holes in their rotation, aren’t expected to tender Pelfrey a contract this December, even if they were to offer the maximum 20 percent cut from his $5.687 million contract. Many pitchers have rebounded from Tommy John surgery, so even if the Mets don’t bring him back there will be interest as there is no shortage of teams with pitching needs. If the Mets think they can cut him loose and bring him back at a discount, they should think again because at 28, he’s young enough to where his career isn’t over. Pelfrey is a career 50-54 with a 4.36 ERA and .284 batting average against him. Of all the statistics on his resume, his age is the one most likely to cause the Mets to take a flier on him again. Considering the potential holes in the Mets’ rotation and bullpen and inevitable need for pitching, he might be worth the gamble. If healthy, he could give the Mets close to 200 innings. With Johan Santana gone after 2013, the Mets will need a starter and there are no guarantees from Matt Harvey, Zach Wheeler or Jenrry Mejia. The idea has also been floated of putting Pelfrey in the bullpen with potential of eventually becoming the closer.

NEXT: Matt Harvey

Oct 05

How Mets Answered Preseason Questions

Like all teams, the Mets had questions entering spring training. The Mets, of course, had more than most. At that time I listed the top ten questions facing the 2012 Mets. Let’s take a look back at how the season answered those questions. Some were in the positive, others not.

1) QUESTION: To what degree will the Wilpon’s financial problems impact the Mets?  

ANSWER: Did you see any new faces of consequence added at the trade deadline? Nope, I didn’t think so. Despite a strong first half, the Mets had issues – notably the bullpen – which they did not address at the end of July. Failing to improve the team, the Mets spiraled down in the second half. While the Mets received a favorable verdict in the Madoff case – they have two more years before they have to pay off – it will not induce GM Sandy Alderson to significantly enter the free agent market. The Mets spent $100 million this year on player salaries and don’t expect them to pay much more than that in 2013.

2) QUESTION: What will we get from Johan Santana?

ANSWER: Actually more than anticipated, including the first no-hitter in franchise history. There remains speculation throwing 134 pitches in that game might have derailed him. Even though there were no arm issues, Santana did lose his command and struggled in the second half before being shut down with an injury. The Mets are on the hook for $31 million more to Santana next year, including a buyout.

3) QUESTION: How long will David Wright remain a Met?

ANSWER: Well, he’s still here and Alderson said retaining him will be an offseason priority. Because of a good first half Wright’s name didn’t come up at the trade deadline as Jose Reyes’ did the year before. Wright proved to the Mets his durability this season and had a good season, hitting .306 with 21 homers and 93 RBI. How much better could it have been had he not slumped trying to carry the team in the second half?

4) QUESTION: Which Mike Pelfrey will we see?

ANSWER: He was good while he lasted, but was shutdown early with an injury and underwent surgery to his elbow. Pelfrey might not be ready until May or June, making it highly unlikely for the Mets to tender him a contract despite Terry Collins’ urging. After a seemingly breakthrough 2010 season, Pelfrey regressed dramatically last year. Overall, Pelfrey has not lived up to expectations. The only way I see him staying with the Mets if he were to re-sign with them at a discount, but with Scott Boras his agent, don’t count on it.

5) QUESTION: What is the configuration of the bullpen?

ANSWER: That was supposed to be Alderson’s priority last winter, but it wasn’t to be as the pen factored greatly in the second-half swoon. Frank Francisco was the primary closer, but finished the season with tendinitis. Bobby Parnell pitched considerably better later in the season and will likely enter spring training in a set-up role if Francisco is healthy. The Mets received promising production from lefties Josh Edgin and Robert Carson. Look for Jon Rauch to be a part of the housecleaning.

6) QUESTION: Is Ruben Tejada the answer as Jose Reyes’ replacement?

ANSWER: That’s still up in the air over the long haul, but for now Tejada is the right fit. Tejada has a great glove, and his .289 average was better than one could have expected. With other pressing needs, Tejada showed enough to where the Mets don’t have to shop for a shortstop this winter.

7) QUESTION: Can Daniel Murphy make it at second base?

I don’t think we’ll see the second coming of Wally Backman, let alone Ryne Sandberg or Roberto Alomar. Murphy’s range could be better, but he showed promise this summer that the position isn’t a lost cause for him. He was less awkward around the bag and made most of the plays. His footwork on the double-play needs to get better. Overall, he showed enough to where the Mets don’t need to sign a second baseman in the offseason.

8) QUESTION: How healthy is Ike Davis?

ANSWER: There was speculation the virus was a contributor to a poor first half, but he refutes that notion. Not wanting to shatter his confidence, and probably moreso that there weren’t other alternatives, the Mets didn’t send him down when he hovered under .200. Davis responded with a strong second half and finished with over 30 homers.

9) QUESTION: What’s the make up of the rotation?

ANSWER: It changed considerably, beginning with Pelfrey’s injury. Dillon Gee and Santana also went down. Chris Young was brought in and gave them over 100 innings. The positive developments were Jon Niese taking another step and the emergence of Matt Harvey. Most positive of all was R.A. Dickey, who won 20 games to become a Cy Young Award candidate. Dickey has gone from journeyman to an offseason priority to be re-signed. 

10) QUESTION: Will it ever happen for Jason Bay with the Mets?

ANSWER: The newest theory is Bsy’s concussion last year caused him to be sluggish at the plate. It’s only speculation. A greater speculation is it won’t happen for Bay, who has given the Mets nothing for the $66 million they’ll pay him. Not even moving in the fences helped Bay. The Mets are just counting the days until he’s off the books.